SELARL PHARMACIE DE SAVERDUN : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE SAVERDUN is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAVERDUN (09700), this company of category PME shows in 2022 a revenue of 4.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE SAVERDUN (SIREN 529489999)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 4 361 407 € 4 104 719 € 3 768 370 € 3 793 330 € 3 560 048 € 3 489 901 € N/C
Net income 330 536 € 339 653 € 225 033 € 296 671 € 219 053 € 219 200 € 196 305 € 204 144 € 182 422 €
EBITDA N/C N/C 329 036 € 425 912 € 330 556 € 328 749 € 292 853 € 326 306 € -2 977 974 €
Net margin N/C N/C 5.2% 7.2% 5.8% 5.8% 5.5% 5.8% N/C

Revenue and income statement

In 2024, SELARL PHARMACIE DE SAVERDUN generates positive net income of 331 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 182 k€ -> 331 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

330 536 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

117.527%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

41.228%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.5%

Solvency indicators evolution
SELARL PHARMACIE DE SAVERDUN

Sector positioning

Debt ratio
117.53 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average -10 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DE SAVERDUN (117.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
41.23% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average +15 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DE SAVERDUN (41.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
8.6 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of SELARL PHARMACIE DE SAVERDUN (8.60) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 299.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

299.275

Liquidity indicators evolution
SELARL PHARMACIE DE SAVERDUN

Sector positioning

Liquidity ratio
299.27 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent +19 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DE SAVERDUN (299.27) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
1.71x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average

In 2022, the interest coverage of SELARL PHARMACIE DE SAVERDUN (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DE SAVERDUN

Positioning of SELARL PHARMACIE DE SAVERDUN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DE SAVERDUN is estimated at 4 614 526 € (range 3 213 483€ - 6 903 596€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
3213k€ 4614k€ 6903k€
4 614 526 € Range: 3 213 483€ - 6 903 596€
NAF 5 année 2024

Valuation method used

Net Income Multiple
330 536 € × 14.0x = 4 614 527 €
Range: 3 213 484€ - 6 903 596€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE SAVERDUN with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE DE SAVERDUN

What is the revenue of SELARL PHARMACIE DE SAVERDUN ?

The revenue of SELARL PHARMACIE DE SAVERDUN in 2022 is 4.4 M€.

Is SELARL PHARMACIE DE SAVERDUN profitable?

Yes, SELARL PHARMACIE DE SAVERDUN generated a net profit of 331 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DE SAVERDUN ?

The headquarters of SELARL PHARMACIE DE SAVERDUN is located in SAVERDUN (09700), in the department Ariege.

Where to find the tax return of SELARL PHARMACIE DE SAVERDUN ?

The tax return of SELARL PHARMACIE DE SAVERDUN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE SAVERDUN operate?

SELARL PHARMACIE DE SAVERDUN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.